Abstract:Rationale. Pathological cardiac remodeling serves as a vital mechanism during the progression from myocardial infarction (MI) to chronic heart failure (CHF). Nobiletin (NOB), an active monomer extracted from the peel of citrus fruit, has been reported to have beneficial effects in cardiovascular diseases. Our study was aimed at describing the specific mechanisms through which NOB protects against pathological cardiac remodeling after MI. Materials and Methods. C57BL/6 mice were treated with coronary artery ligation to generate an MI model, followed by treatment for 3 weeks with NOB (50 mg/kg/d) or vehicle (50 mg/kg/d), with or without the peroxisome proliferator-activated receptor gamma (PPARγ) inhibitor T0070907 (1 mg/kg/d). Cardiac function (echocardiography, survival rate, Evans blue, and triphenyl tetrazolium chloride staining), fibrosis (Masson’s trichrome staining, quantitative real-time polymerase chain reaction (qRT-PCR), and western blot (WB)), hypertrophy (haematoxylin-eosin staining, wheat germ agglutinin staining, and qRT-PCR), and apoptosis (WB and terminal deoxynucleotidyl transferase dUTP nick-end labelling (TUNEL) staining) were evaluated. Hypoxia-induced apoptosis (TUNEL, WB) and phenylephrine- (PE-) induced pathological hypertrophy (immunofluorescence staining, qRT-PCR) models were established in primary neonatal rat ventricular myocytes (NRVMs). The effects of NOB with or without T0070907 were examined for the expression of PPARγ and PPARγ coactivator 1α (PGC1α) by WB in mice and NRVMs. The potential downstream effectors of PPARγ were further analyzed by WB in mice. Results. Following MI in mice, NOB intervention enhanced cardiac function across three predominant dimensions of pathological cardiac remodeling, which reflected in decreasing cardiac fibrosis, apoptosis, and hypertrophy decompensation. NOB intervention also alleviated apoptosis and hypertrophy in NRVMs. NOB intervention upregulated PPARγ and PGC1α in vivo and in vitro. Furthermore, the PPARγ inhibitor abolished the protective effects of NOB against pathological cardiac remodeling during the progression from MI to CHF. The potential downstream effectors of PPARγ were nuclear factor erythroid 2-related factor 2 (Nrf-2) and heme oxygenase 1 (HO-1). Conclusions. Our findings suggested that NOB alleviates pathological cardiac remodeling after MI via PPARγ and PGC1α upregulation.

Inhibition of eNOS Partially Blunts the Beneficial Effects of Nebivolol on Angiotensin II-Induced Signaling in H9c2 Cardiomyoblasts

Nebivolol Combined with Tetrahydrobiopterin Affects Diastolic Function in Spontaneously Hypertensive Rats Via the Nitric Oxide/cyclic Guanosine Monophosphate Signalling Pathway

Nitric Oxide Synthase Inhibition Abolishes Exercise-Mediated Protection Against Isoproterenol-Induced Cardiac Hypertrophy in Female Mice.

Nobiletin Attenuates Pathological Cardiac Remodeling after Myocardial Infarction Via Activating PPARγ and PGC1α

Inhibition of endogenous nitric oxide synthase potentiates nitrovasodilators in experimental pulmonary hypertension

The Role of Inos-Derived NO in the Antihypertrophic Actions of B-type Natriuretic Peptide in Neonatal Rat Cardiomyocytes

Nitric Oxide Regulation of Myocardial O2 Consumption and HEP Metabolism.

Nebivolol in oral subacute treatment prevents cardiac post-ischemic dysfunction in rats, but hyperthyroidism reduces this protection: mechanisms involved

[Molecular Mechanism of Nitric Oxide in Preventing Cardiomyocytes from Hypertrophic Response Induced by Angiotensin II].

Anti-hypertrophic and Anti-Oxidant Effect of Beta3-Adrenergic Stimulation in Myocytes Requires Differential Neuronal NOS Phosphorylation

Cardioprotective effect of beta-3 adrenergic receptor agonism: role of neuronal nitric oxide synthase.

Abstract 17320: Signaling Mechanisms Involved in Beta3-adrenergic Receptor Regulation of Nnos in Isolated Cardiomyocytes

Enhanced eNOS/nitric oxide production by nebivolol interferes with TGF-β1/Smad3 signaling and collagen I deposition in the kidney after prolonged tacrolimus administration

Nebivolol Improves Obesity-Induced Vascular Remodeling by Suppressing NLRP3 Activation

Stimulation of platelet nitric oxide production by nebivolol prevents thrombosis

Effects of Tetrahydrobiopterin Combined with Nebivolol on Cardiac Diastolic Function in SHRs.

Naringenin Inhibits N-G-nitro-L-arginine Methyl Ester-Induced Hypertensive Left Ventricular Hypertrophy by Decreasing Angiotensin-Converting Enzyme 1 Expression

Abstract 92: the Protective Effect of Β3-Adrenergic Signaling Occurs Via Differential Phosphorylation of Nnos in Cardiac Myocytes

Nobiletin, a Polymethoxy Flavonoid, Protects Against Cardiac Hypertrophy Induced by Pressure-Overload via Inhibition of NAPDH Oxidases and Endoplasmic Reticulum Stress.

1,8-Cineole Ameliorates Endothelial Injury and Hypertension Induced by L-NAME Through Regulation of Autophagy Via PI3K/mTOR Signaling Pathway

[Role of Mitogen-Activated Protein Kinase in the Inhibition of Myocardial Hypertrophy by Nitric Oxide in Renovascular Hypertensive Rats].